The American Journal of Cardiology · 2024 · 23 citations · 22 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical CardiologyDiabetologyAcute Coronary SyndromesCardiovascular DiseaseCoronary Artery DiseaseDiabetes MellitusIschemic Heart DiseaseSodium-glucose Cotransporter 2 InhibitorsAcute Coronary Syndrome ManagementCoronary Artery Disease PharmacotherapyDiabetic CardiomyopathyIschemic Heart Disease PharmacologySodium-glucose Cotransporter 2 Inhibition
22
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey et al. · New England Journal of Medicine · 2017 · 7.8K citations · Full text
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker, Javed Butler, Gerasimos Filippatos et al. · New England Journal of Medicine · 2021 · 4.6K citations · Full text
Medicine, Cardiology, Pharmacology +14